创建

登录 ReadmeX

或

了解我们如何处理你的信息: 隐私政策

ReadmeX

陪你读懂 AI 动态

今天,想先了解什么?

选一份动态总结,或直接聊聊你的问题。

社区和关注动态总结只属于你自己。

资讯

月之暗面将Kimi转向科学研究

AI 总结

据The Decoder报道,由于看到编程领域的收益趋缓,月之暗面正将其Kimi语言模型从编程转向生物、化学和制药研究。月之暗面国际总监Giacomo Ficari在里斯本Web Summit上表示,与法律、金融或编程相比,科学领域需要更智能的模型。DP Technology正将Kimi K3.1 Pro接入其研究助手BioMaster。在一项合作方测试中,该系统用90分钟分析了3,696个小鼠胰岛细胞的基因数据,并标出100个候选基因;人工耗时估算为4小时。报道还指出,领先模型在TCSExam上生成了可验证的证明,但未能独立解决任何公开猜想。花旗6月对50名美国研究负责人的调查显示,只有24%预计AI会明显提升药物研发成功率。

深度见解

此次转向标志着Kimi在战略上进入生物、化学和制药研究领域。不过,报道指出,完全独立的AI突破仍很遥远,且只有少数受访研究负责人预计AI会明显提升药物研发成功率。

Moonshot AI pivots Kimi models from coding to science as benchmark gains flatten

Manuel Uth

Nov 16, 2026

Because Moonshot AI sees diminishing returns in coding, the Beijing startup is redirecting its Kimi language models toward biology, chemistry, and pharma research. International director Giacomo Ficari said at the Web Summit in Lisbon that science demands smarter AI models than law, finance, or code.

Beijing startup DP Technology is integrating Kimi K3.1 Pro into its research assistant BioMaster. In one test, the AI analyzed gene data from 3,696 mouse pancreatic cells and flagged 100 candidate genes in 90 minutes instead of an estimated four hours of human work.

Fully independent breakthroughs are still a long way off. On TCSExam, a 100-problem theoretical CS benchmark, leading models produced verifiable proofs but couldn't crack any open conjectures alone. US rivals hit similar limits. Anthropic's Claude found an enzyme system in September, but mathematicians criticized OpenAI's claimed math and physics breakthroughs. The pharma industry isn't sold yet either. A June Citi survey of 50 US research leaders found 72 percent already using AI broadly, but only 24 percent expect it to noticeably improve drug development success rates.

#Moonshot AI#Kimi K3.1 Pro#DP Technology#BioMaster

原文约 1 分钟读完阅读原文
群聊

还没有评论,来说说你的看法。